Lipoxygenases (LOXs) form a heterogeneous family of lipid‐peroxidizing enzymes, and several LOX‐isoforms (12/15‐LOX, 5‐LOX) have been implicated in atherogenesis. However, the precise role of these enzymes is still a matter of discussion. 12/15‐LOXs are capable of oxidizing lipoproteins (low‐density lipoprotein (LDL), high‐density lipoprotein (HDL)) to atherogenic forms, and functional inactivation of this enzyme in murine atherosclerosis models slows down lesion formation. In contrast, rabbits that overexpress this enzyme were protected from lesion formation when fed a lipid‐rich diet. To contribute to this discussion, we recently investigated the impact of 12/15‐LOX overexpression on in vitro foam cell formation. When 12/15‐LOX‐transfected J774 cells were incubated in culture with modified LDL, we found that intracellular lipid deposition was reduced in the transfected cells when compared with the corresponding control transfectants. This paper briefly summarizes the current status of knowledge on the biological activity of different LOX‐isoforms in atherogenesis and will also provide novel experimental data characterizing the role of 12/15‐LOX in cellular LDL modification and for in vitro foam cell formation.